Aurobindo Pharma's CuraTeQ Secures Positive EMA Opinion for Zefylti Biosimilar

CuraTeQ Biologics, a subsidiary of Aurobindo Pharma, received a positive opinion from EMA's CHMP for its filgrastim biosimilar, Zefylti. This marks the first biosimilar from Aurobi...